C. Nichols
Corporate Officer/Principal at ALKERMES PLC
Net worth: 2 M $ as of 2024-03-30
Profile
C.
Todd Nichols is currently the Chief Commercial Officer & Senior Vice President at Alkermes Plc.
Prior to his current position, he served as the Senior Vice President-Sales & Marketing at Alkermes, Inc. from 2019 to 2020.
Before that, he was the Vice President-Marketing & Sales at Celgene Corp.
from 2018 to 2019.
He also held a position as Vice President-US Sales & Field Operation at Biogen, Inc. Mr. Nichols completed his undergraduate degree at Elon University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-17 | 65,911 ( 0.04% ) | 2 M $ | 2024-03-30 |
C. Nichols active positions
Companies | Position | Start |
---|---|---|
ALKERMES PLC | Corporate Officer/Principal | - |
Former positions of C. Nichols
Companies | Position | End |
---|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Sales & Marketing | 2020-04-30 |
CELGENE | Sales & Marketing | 2018-12-31 |
BIOGEN INC. | Sales & Marketing | 2016-12-31 |
Training of C. Nichols
Elon University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BIOGEN INC. | Health Technology |
ALKERMES PLC | Health Technology |
Private companies | 2 |
---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- C. Nichols